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Abstract 
This research reviews cases of necrotizing fasciitis which is commonly known as flesh eating bacteria, a rare 
bacterial infection. It can spread rapidly in the victim’s body and can cause death. The literature shows that a high 
percentage of victims are affected by Group A Streptococcus (Group A Strep). Studies have shown that, many 
victims experience a break in the skin or blunt trauma. The disease is contracted when there is a break in the skin 
or when an open wound is exposed to coastal salt water. The studies show that anyone can get these bacteria, but 
victims are more likely to have other health problems such as diabetes, kidney disease and cancer. Once someone 
is infected by these fatal bacteria, early intervention such as surgery, antibiotic and proper wound care can stop 
the infection and prevent further injury or death.     
Keywords: Necrotizing Fasciitis; Group A Streptococcal bacteria; Necrotizing soft tissue infection; gas gangrene; 
surgical debridement. 
1. Introduction  
Flesh eating bacteria is commonly known as necrotizing fasciitis. This infection is usually caused by Group A 
Streptococcus (GAS). 
------------------------------------------------------------------------ 
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In Cunningham’s [1] article, he stated that the bacteria are an uncommon, critically serious infection of the 
subcutaneous tissue and fascia with relative sparing of the skin and muscle, both of which may be infected 
secondarily. Necrotizing soft tissue infections (NSTIs) are characterized by subepithelial invasion of the soft tissue 
by microorganisms, resulting in tissue edema, vascular thrombosis, and lymphocytic infiltration [1].  Group A 
Streptococcus (GAS) was first described in 1874 by Billroth, who demonstrated its presence in wound infections 
and erysipelas. Pasteur identified GAS as the cause of puerperal sepsis in 1879. In 1884, Rosenbach gave it the 
name Streptococcus pyogenes. Lancefield made a major contribution in the field of epidemiology in 1933, when 
she classified β-hemolytic streptococci in different groups [2]. Necrotizing fasciitis is potentially limb and life 
threatening soft tissue infection. It has been recognized clinically since the time of Hippocrates. It was first 
documented in modern surgical literature by Joseph Jones as “hospital gangrene.” The British tabloids have 
recently coined the term ‘‘flesh-eating bacteria’’ to describe the Group A Streptococci (GAS) that cause invasive 
necrotizing infections and have suggested that epidemics of strep infections are imminent. Such aggrandizement 
is unfounded, yet it has served to heighten public awareness of this sporadic, but serious infectious disease [3].  In 
the 1990’s it became popularly known in the media as the “flesh-eating bacteria” disease. This condition is 
associated with a high mortality rate, ranging from 9% to 29%. Various risk factors for mortality have been 
analyzed, however most of the literature studies combined incidence of necrotizing fasciitis involving both upper 
limb and lower limbs [4]. It should be noted that patients with flesh eating bacteria are always misdiagnosed 
during the initial stage of the disease.  If diagnosed early, mortality and amputation rates could be reduced. Patients 
with necrotizing fasciitis usually present with the triad of pain, swelling and erythema. It is often diagnosed as 
cellulitis or abscess. The most consistent feature of early necrotizing fasciitis is that the pain is out of proportion 
to the swelling or erythema [5].   Chee and his colleagues conducted a study in 2009 with a total of forty one (41) 
patients presented with necrotizing fasciitis of the lower limb and reviewed cases over one year. Results show that 
the mortality rate for necrotizing fasciitis of the lower limb is quite high at 19.5%. Comparison among necrotizing 
fasciitis patients reveals that higher mortality rate is seen among those patients with advanced age and those 
presented with initial high pre-operative creatinine levels. Sex, pre-morbid diabetes mellitus, duration from initial 
symptoms to presentation for treatment and presence of Streptococcus Group A were not associated with an 
increased mortality rate [4]. 
 
Figure 1 [6] 
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Necrotizing fasciitis involving the dorsum of the foot of a three-year-old child following a recent  
Herpes Zoster infection 
 
Figure 2 [7] 
Necrotizing Fasciitis of the upper part of left arm 
Since the 1980s, there has been a marked increase in the recognition and reporting of highly invasive Group A 
Streptococcal (GAS) infection associated with shock and organ failure, with or without necrotizing fasciitis [3]. 
Although flesh eating bacteria is fatal in most cases, early diagnosis and intervention is critical in saving the 
victim. Cunningham and his colleagues argued that the bacterium moves rapidly in the subcutaneous tissue and 
does not spare the skin and muscles. Necrotizing soft tissue infections (NSTIs) are characterized by subepithelial 
invasion of the soft tissue by microorganisms, resulting in tissue edema, vascular thrombosis, and lymphocytic 
infiltration. Muscle necrosis may result from untreated infection [1]. The diagnosis is often missed initially 
because of the paucity of clinical signs and symptoms or the clinician’s lack of familiarity with the condition [1]. 
Once the diagnosis is suspected, the patient needs to be adequately stabilized and then taken to the operating room 
for surgical exploration and debridement. Negative outcomes result from delay in diagnosis, inadequate surgical 
debridement, and complications of sepsis [1]. 
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Figure 3 [8] 
The patient after complete surgical debridement, with extension of the resection from the left shoulder down, 
including some of the pectoralis, down to the iliac crest and extending to the midline anteriorly over the abdominal 
cavity. 
 
 
Figure 4 [9]: Anterior (A) and posterior (B) views of the split-thickness skin graft.                    
The purpose of this research paper is to review various cases of “flesh eating bacteria” in the United States over a 
period of time. Demographic factors and co-morbid conditions associated with necrotizing fasciitis (flesh eating 
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bacteria) will be discussed; also early diagnosis and treatment methods.  
2. Materials and Methods 
Computerized literature searches were performed (Google Scholar 1990 to 2019; Pub Med Central 2014 to 2019; 
a database specialized in life science journals) to identify all studies on the subjects. Publications thus found were 
screened for further relevant articles in their bibliographies. In addition, leading experts and national societies 
were contacted and asked for further materials. Studies were admitted into the present review if they related to 
flesh eating bacteria in the United States over a specific period of time.  Search terms included “flesh eating 
bacteria”, “necrotizing fasciitis”, “group A streptococcal bacteria”, “necrotizing soft tissue infection”, “gas 
gangrene” and “surgical debridement.” Additional information was obtained by a detailed review of the references 
listed. 
3. Results  
Kehrl [10] reported a case of Group a Streptococcus Necrotizing Fasciitis recognized with Point of Contact 
Ultrasound and subsequent negative findings on computed tomography and magnetic resonance imaging. He 
argued that this flesh eating bacteria is challenging in diagnosing and ultrasound should be included in helping 
clinicians make early diagnosis to optimize outcomes.   Figure 5 depicts the possible depths of involvement of 
skin and soft tissues infections and the accompanying diagnoses. Superficial infections such as erysipelas, 
impetigo, folliculitis, furuncles, and carbuncles are located at the epidermal layer, while cellulitis reaches into the 
dermis. Deeper infections cross the subcutaneous tissue and become fasciitis or myonecrosis. However, the depth 
of infection is difficult to discern on examination; laboratory studies can help with this assessment [10].  Points 
are allocated for high C-reactive protein, creatinine, glucose, and white blood cell count values and for low red 
blood cell counts and sodium levels. Patients with a score of five points or less are considered at low risk, while 
those with six or more points are considered to be at least at intermediate risk of necrotizing fasciitis [12]. 
 
Figure 5 [11] 
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Depth of involvement in skin and soft- tissue infections 
Flesh eating bacteria is a rare condition but it is extremely serious. Around 1 in 4 affected individual die from it. 
Since its onset is spontaneous most people affected with it are generally in good health before infection [10]. 
Necrotizing fasciitis has a mortality rate of 23.5%, but this may be reduced to 10% with early detection and prompt 
surgical intervention [12].  Wong, Chin-Ho and his colleagues [14] created the LRINEC or Laboratory Risk 
Indicator for Necrotizing Fasciitis, which is done to determine the risk to the affected individual. Since necrotizing 
fasciitis is very difficult to diagnose, clinicians must maintain a high level of suspicion and use the Laboratory 
Risk Indicator for Necrotizing Score (LRINEC) score (Table 1) to trigger early surgical evaluation. Surgical 
exploration is the only way to definitively diagnose necrotizing fasciitis [12]. The Laboratory Risk Indicator for 
Necrotizing Fasciitis (LRINEC) score was developed as a diagnostic tool to potentially aid practitioners in early 
detection of Necrotizing Fasciitis (NF).  A LRINEC score between 0 and 13 can be calculated based on levels of 
serum leukocytes, glucose, sodium, C-reactive protein (CRP), creatinine, and hemoglobin. All six components of 
the LRINEC score are required for valid calculation. LRINEC scores ≥8 fall in the high-risk category, LRINEC 
scores of 6–7 are moderate risk, while scores ≤5 are considered low risk. Previous evidence suggested that a 
patient with a LRINEC ≥6 should be further evaluated for NF diagnosis [15]. 
Table 1: LRINEC  [13] 
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Arif and his colleagues [16] estimated the mortality burden of necrotizing fasciitis in the United States over a 10-
year period. They also sought to characterize demographic factors and comorbid associated with necrotizing 
fasciitis during this period. Data from the National Center for Health Statistics was used to obtain data on 
necrotizing fasciitis. Information from death certificate from all 50 states, including demographic and cause of 
death for the year 2003 – 2013 were included. A total of 9,871 necrotizing fasciitis deaths in the United States 
between 2003 and 2013 (Table 2) were identified. This corresponded to a summary mortality rate of 4·8 deaths/ 
1 000 000 p-yr. Arif and his colleagues show necrotizing fasciitis  was reported as the underlying cause in 4185 
(42%) deaths, and a contributing cause of death in 5686 (58%) deaths. An autopsy was reported in 885 (9%) of 
9871 deaths, and autopsy status was unknown in an additional 1034 (11%) deaths [16].  An underlying 
microbiological diagnosis was provided in 546 (6%) of 9871 deaths. Of these 546 deaths, streptococcal infection 
was identified in 260 (48%) deaths, staphylococcal infection in 119 (22%) deaths, Gram-negative infection in 114 
(21%) deaths, gas gangrene in 28 (5%) deaths, anaerobic infection in 15 (3%) deaths, and a mixed infection was 
identified in 10 (2%) deaths.  Thus, type II (mono-microbial) NF due to either Staphylococcus or Streptococcus 
was identified in 379 (69%) of 546 deaths where a microbiological diagnosis was included in the cause-of-death 
information [16]. Arif and his colleagues argued that advanced age was associated with an increasing rate of 
necrotizing fasciitis as compared to individuals who were 35-44 years. Men were 1.25 times greater than women 
to be infected by these bacteria. Blacks’ mortality rate was doubled compare to whites. However, Arif and his 
colleagues demonstrate that the rate in Native Americans was nearly three times the rate in white individuals. For 
Asian there was a great contrast which showed the mortality rate was 28% more that white individuals.  Arif and 
his colleagues used ICD-10 codes by block to describe the most common conditions included in the death 
certificates for necrotizing fasciitis related deaths. (Table 4). Diabetes mellitus was the most common comorbid 
condition, identified in 21% of all deaths. Renal disease, ischemic heart disease, and substance use were also 
frequently reported as comorbid conditions. Kehrl [10] reveals a 54-year-old diabetic woman who was seen in the 
Emergency Department with complaints of atraumatic right foot and lower leg pain associated with fever. There 
were concerns regarding necrotizing fasciitis and the patient had a point of contact ultrasound performed. The 
result was consistent with necrotizing fasciitis since there was a thickened deep fascia with fluid tracking along 
the deep fascial plane and fluid pockets measuring 6 mm in depth. Patient was referred for surgical consultation 
and a Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) of the patient's lower extremity were 
performed. Both tests interpretation by the radiologist was consistent with cellulitis.  Patient eventually began to 
experience septic shock and multisystem organ started to fail. So patient was eventually taken to the operating 
room for further intervention. The findings conducted showed patient was infected with necrotizing fasciitis since 
cultures in the operating room were positive for Streptococcus pyogenes. Kehrl concluded that necrotizing fasciitis 
is a surgical emergency and it’s critical to have early and accurate diagnosis so that aggressive management can 
be implemented for optimal outcomes.          
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Table 2:  Annual frequency and rate of necrotizing fasciitis related deaths in the U.S., 2003–2013 [16] 
 
Table 3: Necrotizing fasciitis-related mortality rates/1 000 000 p-yr. [16] 
 
 
Table 4: Most common comorbid diagnoses in individuals with necrotizing fasciitis-related deaths in the United 
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States [16] 
 
Table 5: Medical conditions associated with necrotizing fasciitis (NF) deaths in the United States, 2003–
2013[16] 
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Table 6: Places in the United States Where People Have Reported Contracting Flesh-Eating Bacteria in 2019                                 
 
Table 6 demonstrates that most people in the United States contracts necrotizing fasciitis (flesh eating bacteria) 
along the warm coastal waters of the states bordering the warm waters of the Gulf of Mexico. The map shows 
that the bacteria can also be found along the Atlantic and Pacific coasts. 
3.1.     Strain Specifics 
A review of the literature demonstrates that there are many strains of bacteria that can cause necrotizing fasciitis. 
Streptococcus pyogenes, staphylococcus aureus, bacteroides fragilis, aermonas hydrophila, and the vibrio bacteria 
are among the many strains. Although the literature states that staphylococcus aureus is the most common strain, 
the Vibrio bacteria is now of great concern since these bacteria are becoming more deadly as a result of warmer 
temperature. All coastal waters and estuaries contain Vibrio bacteria. Although many Vibrio species are harmless, 
several can cause serious disease in humans or animals. Vibrio vulnificus and V. parahaemolyticus are the most 
common types of sometimes deadly foodborne and wound Vibrio infections. Recognized infections 
from Vibrio species are on the rise, and although there is some uncertainty, most researchers predict that climate 
change will increase cases [18].  Studies show that the Vibrio virus is contracted mostly from eating contaminated 
seafood, mainly shellfish or can be through an infection from an open wound while swimming in the ocean. Most 
people with weak immune system could be infected by this virus. Froelich and Noble suggest that most infections 
are unreported, and it is estimated that in the USA approximately 84,000 people contract a food-borne infection 
from Vibrio species every year, the highest rate since nationwide reporting began.                        
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3.2.     Treatment Schemes 
Intravenous Venous (IV) Antibiotics 
Once necrotizing fasciitis is confirmed, it is very important to start Intravenous Venous (IV) antibiotic without 
delay. Initial antibiotic selection should encompass agents with activity against a broad range of organisms, 
including aerobes, methicillin-resistant Staphylococcus aureus (MRSA) and anaerobes. Patient-specific factors 
such as previous antibiotic exposure, concomitant disease states, organ dysfunction, and allergies should be 
considered in the selection of antibiotics [19].  Hakkarainen and his colleagues [20] indicate that broad-spectrum 
antimicrobial therapy should be initiated in all cases of suspected NSTI. Initial empiric therapy should include 
gram-positive, gram-negative, and anaerobic coverage. Local incidence of  MRSA infection should be considered 
and anti-MRSA coverage based on locoregional resistance patterns may be indicated [20].  In treating necrotizing 
soft-tissue infections, the authors have shown that Vancomycin is included for empiric coverage since there is a 
significant local incidence of MRSA infection in their institution's referral region. Our empiric therapy regimen 
consists of 4 antimicrobials: penicillin G, clindamycin, vancomycin, and gentamicin. Penicillin G has significant 
activity against streptococcal and clostridial species. As stated, vancomycin provided empiric coverage for MRSA 
infection. Clindamycin has relatively broad activity, but specifically it has been shown to decrease α-toxin 
production by clostridial species, reduce superantigen M protein by streptococcal species, and suppress 
lipopolysaccharide–induced tumor necrosis factor-α production by monocytes. Gentamicin provides broad 
coverage for many gram-negative rods and anaerobic species [20].  Hakkarainen and his colleagues also argued 
that fluoroquinolones is used instead of gentamicin if patients have a high creatinine level at initial evaluation. At 
this point there is a great concern for acute kidney injury and prevent patient from getting nephrotoxity of 
aminoglycosides. The authors explain that the regimen is continued until microbial culture allows appropriate 
narrowing of coverage, or until operative debridement is complete and the patients become hemodynamically 
stable with a normal or near-normal white blood cell count [20]. 
3.3.      Surgical debridement 
Surgical debridement is critical to save limbs that are infected. Nothing should delay emergent surgical 
debridement and antibiotic administration, as both are important in ensuring survival [19]. Misiakos and his 
colleagues explain that surgical management is indicated especially for patients displaying intense pain and skin 
color change, such as edema and/or ecchymosis, or signs of skin ischemia with blisters and bullae. They suggest 
that patients must be operated on urgently when they present with altered mental status, hypotension, and elevated 
band formed in the differential white blood cell count, and metabolic acidosis [21]. The authors explained that 
incisions are performed parallel to Langer’s lines to achieve better surgical wound healing and less scarring. They 
revealed that surgery also minimizes the overall tissue loss as it inhibits infection spread to the fascial plane, 
reducing the need for amputation. After the release of pus and/or hemorrhagic fluid through incisions, ventricle 
incisions are made, keeping the wound open in order to allow drainage and to remove additional necrotic tissue. 
Misiakos and his colleagues [21] indicate that patients with necrotic fasciitis should be closely monitored during 
the next 24 hours and surgical wounds and tissue viability should also be checked. If the surgical wounds are 
complicated a “second -look” operation with radical surgical debridement will be performed. This type of 
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operation will actually eliminate any residual infection so that patient will be able to heal. Patients with necrotic 
fasciitis can require from 5 up to 40 additional operations, depending on the timing of the first surgical 
debridement, the adequacy of the primary debridement and necrosectomy, signs of hemodynamic instability, and 
concomitant illnesses, all of which are associated with a high mortality rate. Evidence of hemodynamic instability 
demands immediate resuscitation, transfer to an intensive care unit, nutritional support, and enteral feeding [21]. 
3.4.     Hyperbaric oxygen (HBO) therapy 
Hyperbaric oxygen treatment is another recognized therapy where oxygen is forced in the blood stream and 
healing of the tissue is repaired and return to normal. Hyperbaric oxygen (HBO) therapy is a treatment modality 
in which a patient is placed in a high- pressure chamber, resulting in delivery of oxygen at 2-3 times typical 
atmospheric pressure. This leads to arterial oxygen tension as high as 2000 mm Hg with resulting tissue oxygen 
tension of 300 mm Hg. This compares with arterial oxygen tension of 300 mm Hg and tissue oxygen tension of 
75 mm Hg when breathing 100% oxygen at normal atmospheric pressure. The use of HBO is based on animal and 
human studies showing that elevated levels of oxygen at the tissue level reduce edema, stimulate fibroblast growth, 
increase the killing ability of leukocytes by augmenting the oxidative burst, have independent cytotoxic effects 
on some anaerobes, inhibit bacterial toxin elaboration and release, and enhance antibiotic efficacy[20]. Most 
patients diagnosed with necrotizing fasciitis usually experience shock. This is a life-threatening condition when 
the body is not getting enough blood flow. At this stage the cells and organs in the body can be damaged because 
of limited oxygen and nutrients. Main protocol to prevent shock is to use intravenous immunoglobulin (IVIG).  
Kadri and his colleagues [23] identified patients from 2010 to 2014 from 130 hospitals with a diagnosis of 
necrotizing fasciitis and were preparing to undergo surgical debridement.  There were 4127 cases of debrided 
necrotizing fasciitis patients with a diagnosis of shock all from 121 centers. The study showed that 164 patients 
(4%) at 61 centers received IVIG but the subjects were younger with lower comorbidity indices, but had more 
severe illness. Clindamycin and vasopressor intensity were higher among IVIG cases, as was coding for toxic 
shock syndrome (TSS) and group a streptococcus.  In-hospital mortality did not differ between matched IVIG and 
non-IVIG groups (crude mortality, 27.3% vs 23.6%; adjusted odds ratio, 1.00 [95% confidence interval, .55–
1.83]; P= .99). Early IVIG (≤2 days) did not alter this effect (P = .99). Among patients coded for TSS, GAS, 
and/or S. aureus, IVIG use was still unusual (59/868 [6.8%]) and lacked benefit (P = .63). Median length of stay 
(LOS) was similar between IVIG and non-IVIG groups (26 [13–49] vs 26 [11–43]; P = .84). Positive predictive 
values for identifying true NF and debridement among IVIG cases using our algorithms were 97% and 89%, 
respectively, based on records review at 4 hospitals [23]. The authors concluded that adjunctive IVIG was 
administered infrequently in necrotizing fasciitis with shock and had no apparent impact on mortality or hospital 
LOS beyond that achieved with debridement and antibiotics [23].         
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1. Necrotizing fasciitis of left arm 
 
2. After debridement 
Figure 6 [24] 
A Necrotizing fasciitis of the left arm demonstrating ruptured bullae with clear fluid, fixed discoloration and skin 
gangrene. B Thorough debridement of the involved fascia showing underlying tendons and muscle bellies; note 
the extent of the debridement  
 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2019) Volume 48, No  4, pp 125-144 
 
138 
 
1. Necrotizing fasciitis of left foot 
 
2. After debridement 
Figure 7 [25] 
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Necrotizing Fasciitis of the left foot and after debridement 
3.5.      Rehabilitation  
Although necrotizing fasciitis is fatal in most cases, some victims survive since the bacterium was identified in 
the early stage. But survival does not mean that these victims will have positive outcome and live normal lives 
after hospitalization.  Many of these victims have undergone amputation and now have to face the rehabilitation 
process which can be long and painful. In order to gain independence victims have to learn to walk with new 
prosthesis and be able to function independently again. Many victims could end up with a caretaker if they are 
unable to care for themselves. After an extended hospitalization, multiple dressing changes and surgical 
procedures, the survivor of necrotizing soft-tissue infections faces months of continued physical therapy to regain 
functional independence [22].   Light and his colleagues [26] conducted a study on long-term follow-up of a 
registry of patients from 1989 to 2006 who survived a hospitalization for necrotizing fasciitis. The last date of 
follow up was January 1, 2008 in a University-based Burn and Trauma Center. The authors linked the data from 
the Department of Health, Department of Motor Vehicle and the University Hospital Medical Records Department 
in January 2008 to obtain follow up and vital status data. The authors concluded that patients who survive an 
episode of necrotizing fasciitis are at continued risk for premature death; many of these deaths were due to 
infectious causes such as pneumonia, cholecystitis, urinary tract infections and sepsis.   Hakkarainen and 
colleagues [22] conducted interviews with 18 survivors of necrotizing soft-tissue infection. The main focus was 
to understand the patients’ experience after diagnosis of the infection. The main areas that the authors focused on 
were individual factors, relational factors and societal factors. The factors were divided into two categories: factors 
affecting the disease process and recovery and factors that were outcomes of the disease process. Each category 
resulted between one and seven themes which were physical, psychological, relationship, and employment 
aspects. Patients who were interviewed revealed that their quality of life was significantly affected by their disease 
and recovery. The results also demonstrate that many outcomes of importance for patients are not easily assessed 
by traditional measures of outcomes. Hakkarainen and his colleagues work illustrates the multidimensional nature 
of recovery from critical illness. It also represents a massive transition period in the lives of survivors that affects 
the patients, and their family and the patient’s ability to interact with society [22].  Kruppa and his colleagues [27] 
conducted a study to evaluate the midterm outcomes after survival of necrotizing fasciitis. The authors argued that 
immediate radical surgical intervention followed by antibiotic treatment and intensive care is necessary to save 
the patients’ lives. However, the scars, amputations, anus sphincter, and the large areas with mesh graft 
transplantation or free tissue flaps to restore the integument after extremity salvation may lead to permanent 
disability due to joint contractures or hypo- or hyperesthesia. In addition assistive devices and permanent need for 
care might be necessary [27].  A recent study conducted by Pham and his colleagues [28] reported on the 
functional outcomes of patients surviving necrotizing fasciitis.  The authors evaluated the management and assess 
factors associated with decreased physical function in patients who survived this life-threatening infection. The 
authors reported extremity involvement as an independent factor of a higher functional limitation in patients after 
survival of necrotizing fasciitis. However they also show that a performed amputation had no further impact on 
the functional limitation. Thirty percent of the patients in the population study presented with mild-to-severe 
functional limitations. 
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3.6.    Discussion  
Center for Disease Control (CDC) website [29] explains that necrotizing fasciitis is not a nationally notifiable 
condition. This means that the disease is not required to be reported by the law. This disease can be caused by a 
variety of bacteria. CDC tracks necrotizing fasciitis caused by group A strep with a special system called Active 
Bacterial Core surveillance (ABCs). Since 2010, approximately 700 to 1200 cases occur each year in the United 
States. This is likely an underestimate. According to ABCs data, the number of annual group A strep necrotizing 
fasciitis infections reported to ABCs do not appear to be rising [29]. This data could be an underestimate of the 
people actually affected by the bacteria. Since the CDC does not require this disease to be reported, the numbers 
of victims affected could be higher. The actual data shows a lower number of people affected by the actual disease 
as a result of CDC reporting requirement.   Kehrl recommends using ultrasound to help clinician make early 
diagnosis of necrotizing fasciitis. This method can be very expensive for patients without health insurance and 
physicians might be reluctant to use this as first method in diagnosing the disease as a result of cost saving. The 
literature shows that black mortality rate is doubled compare to whites. One can argue that the lack of health 
insurance and limited health care access might be the main cause of the high mortality rate among blacks. So, one 
could also state that the rate of necrotizing fasciitis will show limited reduction from the use of ultrasound since 
most of the deaths are from blacks with limited access to health care.  The literature shows that cellulitis is 
frequently diagnosed instead of necrotizing fasciitis. A review of the diagram (Figure 5) on the involvement in 
skin and soft-tissue infection, it is very clear that patients could be misdiagnosed since the symptoms are so 
similar. As a result of this similarity in symptom, it is critical that the correct diagnosis be made in the initial 
assessment since the delay in diagnosis can be critical and cause death or amputation.  Table 5 identifies the most 
common condition included on the death certificate for all necrotizing fasciitis patients is diabetes. Patients with 
diabetes are already immunosuppressed since this is a life-threatening condition. It is important that the healthcare 
system provide adequate outreach programs so that this condition can be managed and patients will have a better 
understanding of diet and exercise and the overall proper care of themselves. All the other co morbid conditions 
should be addressed by educating patients on their conditions and therefore reduce the number of patients 
presented with necrotizing fasciitis.    
4. Conclusion 
The current treatment for flesh eating bacteria includes, antibiotics, surgery and intravenously administered 
immunoglobulins. Table 1 provides healthcare professional as well as laboratory personnel the ability to 
collaborate and discuss patients’ risk factors by reviewing blood test results. As a result, an early diagnosis can be 
made and patients will be given the appropriate treatments according to the severity of infection.  Numerous 
reports demonstrate that flesh eating bacteria can cause death if diagnosis is delayed. Therefore health care 
professional should be trained with the current treatments that are available. Since this bacterium is so rare, but 
fatal, most health care professional usually diagnose the patient’s bacteria with cellulitis and as a result of this 
wrong diagnosis, patients’ limbs are amputated or they die. There is no time to waste with these rapid moving 
bacteria. Necrotizing fasciitis is a very rare disease and health care professional are not up to date with the 
appropriate treatment since the disease is so infrequent. In the past decade, this disease is now brought to the 
forefront as a result of improved access to information.  Since there are now newer techniques being developed 
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to help in early and accurate diagnosis, health care manager should ensure that their staff is adequately trained so 
that Staphylococcus A bacteria will always be diagnosed correctly and a patient will not experience unnecessary 
pain. Since clinical manifestation is very important in diagnosing these bacteria, laboratory personnel should be 
aware of the various lab values and report abnormal results to the physician so that a plan of care can be 
immediately implemented. In conclusion, necrotizing fasciitis is difficult to diagnose in the early stage since there 
are nonspecific signs such as swelling, tenderness and erythema at the affected site.  The study confirms that this 
soft tissue infection has similar presentation as cellulitis, it should be diagnosed without delay. For infected 
patients, surgical debridement is critical and this procedure should be implemented immediately to save limbs and 
lives.  This review is important because it describes how the current literature is related to prior research on 
necrotizing fasciitis (flesh eating bacteria). This study advances the study of necrotizing fasciitis by reviewing 
current treatment that did not exist in previous years.    
5.    Constraints/limitation of the Study 
There are potential limitation to this study. There could be bias from the survey conducted on morbidity of patients 
who have been diagnosed with “flesh eating” bacteria. Some patients might not have answered the questions 
correctly as a result of not understanding the survey questions. In addition, as a review article only, no hypothesis 
was tested, and all reports are necessarily anecdotal without specific independent analysis of medicals.   
6. Recommendations 
The research revealed that “flesh eating bacteria” is fatal in most cases. However if the bacterium is identified 
early, the patient will not suffer amputation or death. Based on these findings, future research should be conducted 
so that the medical community will have a better understanding of the current treatment modalities being used as 
well as testing requirements. It is also critical that information be distributed to the public concerning typical areas 
of risk and necessity of carrying hydrogen peroxide for puncture wound cleaning and application to cuts.  
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